Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs

Almost two decades after CFTR was identified as the gene responsible for cystic fibrosis (CF), we still lack answers to many questions about the pathogenesis of the disease, and it remains incurable. Mice with a disrupted CFTR gene have greatly facilitated CF studies, but the mutant mice do not develop the characteristic manifestations of human CF, including abnormalities of the pancreas, lung, intestine, liver, and other organs. Because pigs share many anatomical and physiological features with humans, we generated pigs with a targeted disruption of both CFTR alleles. Newborn pigs lacking CFTR exhibited defective chloride transport and developed meconium ileus, exocrine pancreatic destruction, and focal biliary cirrhosis, replicating abnormalities seen in newborn humans with CF. The pig model may provide opportunities to address persistent questions about CF pathogenesis and accelerate discovery of strategies for prevention and treatment.

[1]  J. T. Fisher,et al.  The porcine lung as a potential model for cystic fibrosis. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[2]  M. Welsh,et al.  Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. , 2008, The Journal of clinical investigation.

[3]  D. Cooper,et al.  Selected physiologic compatibilities and incompatibilities between human and porcine organ systems , 2006, Xenotransplantation.

[4]  A. Chakravarti,et al.  Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. , 2006, Gastroenterology.

[5]  J. Carlin,et al.  Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening , 2005, Pediatric pulmonology.

[6]  A. Taddei,et al.  Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors , 2004, The Journal of general physiology.

[7]  J. Emerson,et al.  Standardized procedure for measurement of nasal potential difference: An outcome measure in multicenter cystic fibrosis clinical trials , 2004, Pediatric pulmonology.

[8]  F. Ratjen,et al.  Cystic fibrosis , 2003, The Lancet.

[9]  D. Look,et al.  Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[10]  C. Wise.  Epithelial cell culture protocols , 2002 .

[11]  J. Christman,et al.  Dysregulated Cytokine Production in Human Cystic Fibrosis Bronchial Epithelial Cells , 2001, Inflammation.

[12]  S. de Bentzmann,et al.  Inflammation and infection in naive human cystic fibrosis airway grafts. , 2000, American journal of respiratory cell and molecular biology.

[13]  M. Wilschanski,et al.  Pathology of pancreatic and intestinal disorders in cystic fibrosis , 1998, Journal of the Royal Society of Medicine.

[14]  G. Roberts,et al.  Oral Self-Mutilation Masquerading as Malignancy , 1998, Journal of the Royal Society of Medicine.

[15]  L. Gawenis,et al.  Increased survival of CFTR knockout mice with an oral osmotic laxative. , 1996, Laboratory animal science.

[16]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[17]  C. Higgins,et al.  Immunocytochemical localization of the cystic fibrosis gene product CFTR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Boucher,et al.  Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium , 1991, British journal of pharmacology.

[19]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[20]  J. Sturgess,et al.  Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. , 1979, The American journal of pathology.

[21]  J. Esterly,et al.  Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. , 1975 .

[22]  D. Andersen.  CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE: A CLINICAL AND PATHOLOGIC STUDY , 1938 .

[23]  G. Downey,et al.  Cystic fibrosis mouse models. , 2007, American journal of respiratory cell and molecular biology.

[24]  M. Welsh,et al.  An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. , 2002, Methods in molecular biology.

[25]  P. Quinton.  Physiological basis of cystic fibrosis: a historical perspective. , 1999, Physiological reviews.

[26]  R. Boucher,et al.  Pathophysiology of gene-targeted mouse models for cystic fibrosis. , 1999, Physiological reviews.

[27]  M. Welsh,et al.  Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. , 1992, The Journal of clinical investigation.

[28]  Esterly,et al.  Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. , 1975, Perspectives in pediatric pathology.